Countable Labs announces advanced RNA quantification module for Countable PCR to support translational, biopharma, and ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.

Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction.

Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

The polymerase chain reaction (PCR) capitalizes on this biological toolbox by manufacturing millions of copies of desired piece of DNA. Invented in 1985 by Kary Mullis, Henry Erlich, and their ...

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...